Merrimack

Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts; the company's mission is to transform cancer care through the design and development of targeted solutions based on a deep understanding of cancer pathways and biologicalmarkers. All of Merrimack's development programs, including four clinical studies and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes.